EyeLash Products:
Revitalash
EyeLash Products and EyeLash Reviews
Section Links:
- ActivLash - Natural Eyelash Growth Serum - Great Results. rated 5/5
- Jan Marini EyeLash New Formula in 2008 Not as effective as its old formula rated 3/5
- MD Lash Factor New Formula in 2009 - rated only 2/5
- Revitalash New Formula in 2009 - rated 1/5
- Latisse Prostaglandin (may cause darkening of your eye color i.e blue/green to dark brown) rated 4/5
Eylash Extension and Growth Serum Products
Paris Hilton and Lindsay Lohan have them, and J. Lo's are made of mink. Madonna's cost $10,000 and are studded with diamonds.
Hollywood is hip to the latest trend. But if you blinked you may have missed it: People are getting eyelash extensions.
"With lash extensions, what they are doing is taking a lash and actually bonding it onto your own lash," said Sally Blenkey-Tchassova, a New York beauty salon owner. "It really looks better than mascara. You don't have the clumpy dirty look. It looks really fresh."
Eyelash extensions started in Asia and made their way west. Unlike traditional false eyelashes that only last one day and are applied on a strip, synthetic eyelash extensions are glued to eyelash hairs one by one with tweezers. The process takes two hours and they last about two months. It typically costs between $300 and $500.
"We are surrounded by celebrity culture and so many celebrity-centric magazines, and everyone wants to look like they are walking down a red carpet," Blenkey-Tchassova said. "This is a way for the average person to look really glamorous really fast."
Beauty salons everywhere are catching on. At the Louis Licari Salon in New York City, eyelash extensions are so popular that appointments must be booked up to months in advance.
For those who do not want to pay the high price or wait for an appointment, a good alternative is semi-permanent lashes. They cost about $50, last about 10 days and take just minutes to apply.
"People are really keen on the semi-permanent eyelashes," Blenkey-Tchassova said. They could come in handy "if you're going away for the weekend or if you have a hot date [with] someone who you haven't had a sleepover with before, and they have to see you in the middle of the night, and you don't want to frighten them. So, I mean, you're going to look great."
 |
ActivLashCost: $129Size: 0.25 ozReview Rating5/5Read Reviews: 1. People Love This Product 2. Larger Than Other Eyelash Products 3. Strong Company with experience 4. Longer, thicker eyelashes - True
|
BOSTON, Dec 26 (Reuters) - Allergan Inc, the maker of Botox, said on Friday that the U.S. Food and Drug Administration has approved its eyelash-thickening drug Latisse.
Latisse is designed to treat a condition known as hypotrichosis of the eyelashes, which means a person does not have enough eyelashes.
The active ingredient (eyelash growth serum) in Latisse is bimatroprost, the same ingredient that is in Allergan's glaucoma treatment Lumigan. Patients taking Lumigan found a side effect of the drug to be eyelash growth, prompting Allergan to study it for the new use.
Latisse is a once-daily prescription treatment that is applied to the base of the upper eyelash with a sterile, single-use-per-eye disposable applicator. Once treatment is stopped, eyelashes will gradually return to where they were prior to treatment.
Allergan said it estimates global peak sales of Latisse solution could top $500 million a year.
Gary Nachman, an analyst at Leerink Swann, said that while approval was expected, "in this cautious environment, every approval through the FDA should be viewed positively."
Latisse is the first prescription product for lengthening eyelashes, making sales forecasting a little difficult.
Larry Biegelsen, an analyst at Wachovia, said he agrees with the company's forecast of more than $500 million. However, "we think the initial uptake will be muted due to the economic situation."
Biegelsen forecasts sales of $30 million in 2009, growing to $310 million in 2012.
Leerink Swann's Nachman said he expects the drug to generate sales of $20 million in 2009, growing to $80 million in 2012.
"We believe the opportunity for Latisse could be much larger, but we still need to do more work on this largely unpioneered market," he said.
Latisse is a structural prostaglandin analog, a lipid compound derived from fatty acids designed to bind to prostaglandin receptors. These receptors are present in hair and are thought to be involved in the development and regrowth of the hair follicle.
Side effects of Latisse can include eye redness, itchy eyes and a darkening of the eyelid skin. Though not reported in clinical studies, Allergan said Latisse may also cause the colored part of the eye to become browner, a condition that might be permanent.
Allergan said it expects to launch the product in the first quarter of 2009.
Allergan's shares rose 1.1 percent to $36.85 on the New York Stock Exchange. (Reporting by Toni Clarke; Editing by Derek Caney and Gunna Dickson)
EyeLash Products & Reviews - How to get longer, fuller & thicker eyelashes.
Review Eyelash products and comments from our reviewers. You can find eyelash reviews and comments from our customers on MD Lash Factor by Neova, Revitalash, and Jan Marini.
Currently there are a lot of eyelash products out there and it is extremely confusing as to which one product to believe or to buy. Some of these products could have the same ingredients and be equally effective but significant price difference is noted when you try buying them.
Our goal is to provide you with the most honest information made available to us and information from our experiences and in-house research done on these products within the last six months. We have also included reviews from people like you who have used different eyelash products.
Please note, that these are just opinions and if you have any questions, please consult your doctor before using any of the products.